Drägerwerk stock gains as margin outlook improves

Published on 09/02/2026 at 16:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock advanced on Xetra as investors reacted to a more confident margin outlook and a fresh analyst target upgrade, while the TecDAX overall traded weaker.

Pop-Art-Comic eines Rettungshelfers mit Gasmelder und Beatmungsmaske auf Halbton-Hintergrund — Drägerwerk AG & Co. KGaA Pop-Art Comic Rettungskraft Gasmelder Beatmungsmaske Sicherheitstechnik DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock (ISIN DE0005550636) traded at 114.80 EUR on Xetra on September 1, 2026, reflecting a gain of 2.14 percent within a weak TecDAX session, according to a report on the Frankfurt market close that highlighted the stock among the day’s stronger technology names.

Stronger performance in a weak TecDAX

In the afternoon trading update dated September 1, 2026, data from a German financial portal showed Drägerwerk shares at 114.80 EUR, up 2.14 percent, while the TecDAX itself finished the session in negative territory, underscoring the stock’s relative strength within the index environment.

The same overview ranked Drägerwerk as one of the top gainers in the TecDAX alongside other technology and industrial names, which underlines that investors were selectively favoring stocks with improving earnings visibility even as the broader market declined.

Analyst lifts price target on higher margins

According to an assessment reported by a financial news and analysis platform on September 2, 2026, an analyst raised the price target for Drägerwerk stock to 130.00 EUR on the back of higher confidence in structurally improved margins.

The report highlighted that recent business development has reinforced the view that Drägerwerk’s profitability can improve over time, which supports the higher target compared with the current Xetra level of 114.80 EUR as of September 1, 2026.

Go deeper

Further coverage of Drägerwerk stock

For more background reports, corporate news and regulatory disclosures on Drägerwerk, the following overview provides a regularly updated collection of articles.

All Drägerwerk stock news at ad-hoc-news.de Investor Relations

Medical and safety technology as core business

Drägerwerk is known for its medical and safety technology products, including ventilators and patient monitoring systems that are used in hospitals worldwide; these segments typically account for a substantial share of the company’s revenue and are central to its margin profile.

Stock near recent highs

With a closing level of 114.80 EUR as of September 1, 2026, Drägerwerk stock is trading close to the raised analyst target of 130.00 EUR, highlighting a remaining upside potential based on the most recent external valuation while also reflecting the stock’s resilient performance in the TecDAX.